David R. Emlet

3.4k citations

24 papers · 2.1k indexed · 1 hit paper · h-index 16

Co-authors: Albert J. Wong Marina Holgado-Madruga David K. Moscatello Andrew K. Godwin Bruce Montgomery John A. Kellum Isamu Okamoto Lawrence C. Kenyon
Topics: Acute Kidney Injury Research (4 papers)Dialysis and Renal Disease Management (3 papers)Protein Kinase Regulation and GTPase Signaling (3 papers)
Cited by: Nephrology Oncology Molecular Biology
Journals: Nature Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States India China

In The Last Decade

David R. Emlet

24 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Grb2-associated docking protein in EGF- and insulin-receptor signalling

1996 578 citations Marina Holgado-Madruga, David R. Emlet et al. Nature profile →

Peers

Countries citing papers authored by David R. Emlet

Since Specialization

Citations

This map shows the geographic impact of David R. Emlet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Emlet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Emlet more than expected).

Fields of papers citing papers by David R. Emlet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Emlet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Emlet. The network helps show where David R. Emlet may publish in the future.

Co-authorship network of co-authors of David R. Emlet

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Emlet. A scholar is included among the top collaborators of David R. Emlet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Emlet. David R. Emlet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	RGS14 regulates PTH- and FGF23-sensitive NPT2A-mediated renal phosphate uptake via binding to the NHERF1 scaffolding protein 2022 ·Journal of Biological Chemistry ·Peter A. Friedman,W. Bruce Sneddon,Tatyana Mamonova,Carolina Montañez‐Miranda,Suneela Ramineni,(unknown),Katherine E. Squires,(unknown),Clara E. Magyar,David R. Emlet,John R. Hepler	14
2	KIM-1-mediated anti-inflammatory activity is preserved by MUC1 induction in the proximal tubule during ischemia-reperfusion injury 2021 ·American Journal of Physiology-Renal Physiology ·Mohammad M. Al‐bataineh,Carol L. Kinlough,Zaichuan Mi,Edwin K. Jackson,Stephanie M. Mutchler,David R. Emlet,John A. Kellum,Rebecca P. Hughey	14
3	Nrf2 activation protects against lithium-induced nephrogenic diabetes insipidus 2020 ·JCI Insight ·Soma Jobbagy,Darío A. Vitturi,Sonia R. Salvatore,(unknown),Pascal Rowart,David R. Emlet,Mark Ross,Scott Hahn,Claudette M. St. Croix,Stacy G. Wendell,Arohan R. Subramanya,Adam C. Straub,Roderick J. Tan,Francisco J. Schöpfer	12
4	Time-dependent effects of histone deacetylase inhibition in sepsis-associated acute kidney injury 2020 ·Intensive Care Medicine Experimental ·Xiao‐Yan Wen,Shengnan Li,(unknown),Xiukai Chen,David R. Emlet,Neil A. Hukriede,John A. Kellum	13
5	Activation of AMP‐activated protein kinase during sepsis/inflammation improves survival by preserving cellular metabolic fitness 2020 ·The FASEB Journal ·Kui Jin,(unknown),Carlos L. Manrique‐Caballero,Hui Li,David R. Emlet,Shengnan Li,Catherine J. Baty,Xiao‐Yan Wen,(unknown),(unknown),(unknown),Núria M. Pastor‐Soler,Kenneth R. Hallows,Edwin K. Jackson,Sruti Shiva,Michael R. Pinsky,Brian S. Zuckerbraun,John A. Kellum,Hernando Gómez	57
6	Sepsis-Associated AKI: Epithelial Cell Dysfunction 2015 ·Seminars in Nephrology ·David R. Emlet,Andrew Shaw,John A. Kellum	66
7	Is acute kidney injury in the early phase of sepsis a sign of metabolic downregulation in tubular epithelial cells? 2015 ·Critical Care ·Kui Jin,(unknown),(unknown),David R. Emlet,Núria M. Pastor‐Soler,(unknown),(unknown),Kenneth R. Hallows,John A. Kellum,Hernando Gómez	3
8	Targeting a Glioblastoma Cancer Stem-Cell Population Defined by EGF Receptor Variant III 2013 ·Cancer Research ·David R. Emlet,Puja Gupta,Marina Holgado-Madruga,Catherine Del Vecchio Fitz,Siddhartha S. Mitra,Shuang-Yin Han,Gordon Li,Kristin C. Jensen,Hannes Vogel,Linda Xu,(unknown),Albert J. Wong	119
9	Antitumor activity of efrapeptins, alone or in combination with 2-deoxyglucose, in breast cancer in vitro and in vivo 2010 ·Cell Stress and Chaperones ·Adonia E. Papathanassiu,Nicholas J. MacDonald,David R. Emlet,Hong Vu	19
10	A simple correction for cell autofluorescence for multiparameter cell‐based analysis of human solid tumors 2006 ·Cytometry Part B Clinical Cytometry ·Charles A. Smith,Agnese A. Pollice,David R. Emlet,Stanley E. Shackney	9
11	HER2 expression as a potential marker for response to therapy targeted to the EGFR 2006 ·British Journal of Cancer ·David R. Emlet,Russell Schwartz,Kathryn Brown,Alessio Pollice,Charles A. Smith,Stanley E. Shackney	27
12	Guidelines for improving the reproducibility of quantitative multiparameter immunofluorescence measurements by laser scanning cytometry on fixed cell suspensions from human solid tumors 2005 ·Cytometry Part B Clinical Cytometry ·Stanley E. Shackney,David R. Emlet,Agnese A. Pollice,Charles A. Smith,Kathryn Brown,(unknown)	2
13	Expression of constitutively activated EGFRvlll in non‐small cell lung cancer 2003 ·Cancer Science ·Isamu Okamoto,Lawrence C. Kenyon,David R. Emlet,Takeshi Mori,(unknown),Susumu Hirosako,Yasuko Ichikawa,Hiroto Kishi,Andrew K. Godwin,Masakazu Yoshioka,Moritaka Suga,Mitsuhiro Matsumoto,Albert J. Wong	107
14	Constitutively active forms of c-Jun NH2-terminal kinase are expressed in primary glial tumors. 2003 ·PubMed ·Hiromasa Tsuiki,Mehdi Tnani,Isamu Okamoto,Lawrence C. Kenyon,David R. Emlet,Marina Holgado-Madruga,(unknown),(unknown),(unknown),Albert J. Wong	85
15	Proteolytic Cleavage of the CD44 Adhesion Molecule in Multiple Human Tumors 2002 ·American Journal Of Pathology ·Isamu Okamoto,Hiromasa Tsuiki,Lawrence C. Kenyon,Andrew K. Godwin,David R. Emlet,Marina Holgado-Madruga,(unknown),(unknown),(unknown),Abhijit Guha,Mitsuhiro Matsumoto,Yukitaka Ushio,Hideyuki Saya,Albert J. Wong	132
16	Elevated JNK activation contributes to the pathogenesis of human brain tumors 2002 ·Oncogene ·Marc A. Antonyak,Lawrence C. Kenyon,Andrew K. Godwin,David C. James,David R. Emlet,Isamu Okamoto,Mehdi Tnani,Marina Holgado-Madruga,David K. Moscatello,Albert J. Wong	90
17	Constitutive Activation of Phosphatidylinositol 3-Kinase by a Naturally Occurring Mutant Epidermal Growth Factor Receptor 1998 ·Journal of Biological Chemistry ·David K. Moscatello,Marina Holgado-Madruga,David R. Emlet,Bruce Montgomery,Albert J. Wong	245
18	Subsets of Epidermal Growth Factor Receptors during Activation and Endocytosis 1997 ·Journal of Biological Chemistry ·David R. Emlet,David K. Moscatello,(unknown),Albert J. Wong	66
19	Grb2-associated binder-1 mediates phosphatidylinositol 3-kinase activation and the promotion of cell survival by nerve growth factor 1997 ·Proceedings of the National Academy of Sciences ·Marina Holgado-Madruga,David K. Moscatello,David R. Emlet,(unknown),Albert J. Wong	230
20	A Grb2-associated docking protein in EGF- and insulin-receptor signallingbreakdown → 1996 ·Nature ·Marina Holgado-Madruga,David R. Emlet,David K. Moscatello,Andrew K. Godwin,Albert J. Wong	578

About David R. Emlet

David R. Emlet is a scholar working on Nephrology, Biophysics and Immunology and Allergy, having authored 24 papers that have together received 2.1k indexed citations. Recurring topics across this work include Acute Kidney Injury Research (4 papers), Dialysis and Renal Disease Management (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). The work is most often cited by research in Nephrology (176 citations), Oncology (598 citations) and Molecular Biology (1.3k citations). David R. Emlet has collaborated with scholars based in United States, India and China. Frequent co-authors include Albert J. Wong, Marina Holgado-Madruga, David K. Moscatello, Andrew K. Godwin, Bruce Montgomery, John A. Kellum, Isamu Okamoto, Lawrence C. Kenyon, Andrew Shaw and Xiao‐Yan Wen. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact